Tumor infiltrating lymphocyte approval heralds new era for precision cancer immunotherapy

FDA approval of Iovance’s lifileucel for melanoma shows the promise of tumor-infiltrating lymphocytes for the treatment of solid tumors, with trials ongoing for lung cancer, cervical cancer and more. FDA approval of Iovance’s lifileucel for melanoma shows the promise of tumor-infiltrating lymphocyte...

Ausführliche Beschreibung